Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders

H Jiang, H He, Y Chen, W Huang, J Cheng… - Journal of Experimental …, 2017 - rupress.org
The NLRP3 inflammasome has been implicated in the pathogenesis of a wide variety of
human diseases. A few compounds have been developed to inhibit NLRP3 inflammasome …

Tranilast directly targets NLRP 3 to treat inflammasome‐driven diseases

Y Huang, H Jiang, Y Chen, X Wang, Y Yang… - EMBO molecular …, 2018 - embopress.org
The dysregulation of NLRP 3 inflammasome can cause uncontrolled inflammation and drive
the development of a wide variety of human diseases, but the medications targeting NLRP 3 …

NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasome

JR Coombs, A Zamoshnikova, CL Holley… - Science …, 2024 - science.org
Inflammasomes are multiprotein complexes that drive inflammation and contribute to
protective immunity against pathogens and immune pathology in autoinflammatory …

Targeting the NLRP3 inflammasome in inflammatory diseases

MSJ Mangan, EJ Olhava, WR Roush… - Nature reviews Drug …, 2018 - nature.com
Danger signals are a hallmark of many common inflammatory diseases, and these stimuli
can function to activate the cytosolic innate immune signalling receptor NLRP3 (NOD-, LRR …

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors

X Zhan, Q Li, G Xu, X Xiao, Z Bai - Frontiers in Immunology, 2023 - frontiersin.org
NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) is a cytosolic pattern
recognition receptor (PRR) that recognizes multiple pathogen-associated molecular patterns …

The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases

H Jiang, T Gong, R Zhou - Advances in immunology, 2020 - Elsevier
The NLRP3 inflammasome is a cytoplasmic multiprotein complex, the assembly of which
can be initiated in response to various exogenous or endogenous danger signals …

Strategies for targeting the NLRP3 inflammasome in the clinical and preclinical space

AG Schwaid, KB Spencer - Journal of Medicinal Chemistry, 2020 - ACS Publications
Inhibiting the NLRP3 inflammasome mediates inflammation in an extensive number of
preclinical models. As excitement in this field has grown, several companies have recently …

MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition

RC Coll, JR Hill, CJ Day, A Zamoshnikova… - Nature chemical …, 2019 - nature.com
Inhibition of the NLRP3 inflammasome is a promising strategy for the development of new
treatments for inflammatory diseases. MCC950 is a potent and specific small-molecule …

Pharmacological inhibition of the NLRP3 inflammasome: structure, molecular activation, and inhibitor-NLRP3 interaction

Q Ma - Pharmacological reviews, 2023 - ASPET
The nucleotide-binding, oligomerization domain-like receptor family pyrin domain containing
3 (NLRP3) inflammasome is a multiprotein complex that combines sensing, regulation, and …

Targeting the NLRP3 inflammasome in cardiovascular diseases

S Toldo, E Mezzaroma, LF Buckley, N Potere… - Pharmacology & …, 2022 - Elsevier
The NACHT, leucine-rich repeat (LRR), and pyrin domain (PYD)-containing protein 3
(NLRP3) inflammasome is an intracellular sensing protein complex that plays a major role in …